Constellation Pharmaceuticals Inc (OQ:CNST)

Sector:  Healthcare Industry:  Biotechnology & Medical Research
 
See Regulatory Filings on SEC
Company Contact
Address: 215 1st St Ste 200
CAMBRIDGE MA 02142-1293
Tel: 1-617-7140539
Website: https://www.constellationpharma.com
IR: See website
<
Key People
Mark A. Goldsmith
Independent Chairman of the Board
Jigar Raythatha
President, Chief Executive Officer, Director
Emma Reeve
Chief Financial Officer, Senior Vice President, Treasurer
Adrian Senderowicz
Senior Vice President, Chief Medical Officer
Patrick Trojer
Chief Scientific Officer
Karen Higgins Valentine
Chief Legal Officer, General Counsel
Jessica Christo
Chief Product Development Officer
   
Business Overview
Constellation Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. The Company is primarily if focused on discovering and developing therapeutics that address serious unmet medical needs in patients with cancers associated with abnormal gene expression and drug resistance. The Company has two clinical-stage oncology development programs: the first program is evaluating a compound, CPI-1205, and the other program is evaluating a compound, CPI-0610.
Financial Overview
For the six months ended 30 June 2019, Constellation Pharmaceuticals Inc revenues was not reported. Net loss increased 67% to $40.2M. Higher net loss reflects Research and development - Balancing increase of 61% to $30.4M (expense), General and administrative - Balanci increase of 75% to $4.1M (expense), Personnel related (including stock) increase of 100% to $3.4M (expense).
Employees: 82 as of Feb 28, 2019
Reporting Currency: U.S. Dollars
Enterprise value: $303.64M as of Jun 30, 2019
Annual revenue (TTM): $0.00M as of Jun 30, 2019
EBITDA (TTM): -$77.34M as of Jun 30, 2019
Net annual income (TTM): -$76.08M as of Jun 30, 2019
Free cash flow (TTM): -$63.46M as of Jun 30, 2019
Net Debt Last Fiscal Year: N/A
Shares outstanding: 25,822,696 as of Jul 31, 2019
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization